FIRST MANHATTAN CO. LLC. - SYNTA PHARMACEUTICALS CORP ownership

Quarter-by-quarter ownership
FIRST MANHATTAN CO. LLC. ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q2 2016$01000.0%0.00%
Q1 2016$01000.00%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q3 2016
NameSharesValueWeighting ↓
CAXTON CORP 21,696,894$7,637,00032.03%
Anson Funds Management LP 989,204$348,0000.11%
CAXTON CORP 62,000$22,0000.09%
McQueen, Ball & Associates Inc. 102,742$36,0000.03%
Sheaff Brock Investment Advisors, LLC 320,000$113,0000.01%
Roundview Capital LLC 21,100$7,0000.00%
QCM Cayman, Ltd. 11,197$4,0000.00%
ZACKS INVESTMENT MANAGEMENT 193,406$68,0000.00%
Renaissance Technologies 2,504,200$881,0000.00%
Squarepoint Ops LLC 56,800$20,0000.00%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders